К главе 9

 

Crooke S.T. Progress in antisense therapeutics // Med. Res. Rev. 1996. Vol. 16. P. 319–344.

Dolnick B.J. Naturally occurring antisense RNA // Pharmacol. Ther. 1997. Vol. 75. P. 179–184.

Famulok M. Oligonucleotide aptamers that recognize small molecules // Curr. Opinion Struct. Biol. 1999. Vol. 9. P. 324–329.

Hager A.J., Pollard J.D., Szostak J.W. Ribozymes: aiming at RNA replication and protein synthesis // Chem. Biol. 1996. Vol. 3. P. 717–725.

Hnatowich D.J. Antisense and nuclear medicine // J. Nucl. Med. 1999. Vol. 40. P. 693–703.

Jones J.T., Lee S.-W., Sullinger B.A. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells // Nature Medicine. 1996. Vol. 2. P. 643–648.

Li Y., Breaker R.R. Phosphorylating DNA with DNA // Proc. Natl. Acad. Sci. (USA). 1999. Vol. 96. P. 2746–2751.

Li Y., Breaker R.R. Deoxiribozymes: new players in the ancient game of biocatalysis // Curr. Opinion Struct. Biol. 1999. Vol. 9. P. 315–323.

Marr J.J. Ribozymes as therapeutic agents // Drug Discov. Today. 1996. Vol. 1. P. 94–102.

Sokol D.L., Murrey J.D. Antisense and ribozyme constructs in transgenic animals // Transgenic Res. 1996. Vol. 5. P. 363–371.

Wilson D.S., Szostak J.W. In vitro selection of functional nucleic acids // Annu. Rev. Biochem. 1999. Vol. 68. 611–647.